Carolinas Wealth Consulting’s Pediatrix Medical MD Stock Holding History

Carolinas Wealth Consulting’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-167	Closed	-$1.68K	–	1062
2024 Q1	$1.68K	Sell	167 -4	-2%	-$37	﹤0.01%	816
2023 Q4	$1.59K	Sell	171 -13	-7%	-$134	﹤0.01%	766
2023 Q3	$2.11K	Hold	184	–	–	﹤0.01%	738
2023 Q2	$2.62K	Sell	184 -32	-15%	-$449	﹤0.01%	779
2023 Q1	$3.22K	Hold	216	–	–	﹤0.01%	757
2022 Q4	$3.21K	Sell	216 -8	-4%	-$131	﹤0.01%	755
2022 Q3	$4K	Hold	224	–	–	﹤0.01%	683
2022 Q2	$5K	Buy	224 +24	+12%	+$490	﹤0.01%	658
2022 Q1	$5K	Hold	200	–	–	﹤0.01%	701
2021 Q4	$5K	Sell	200 -2	-1%	-$54	﹤0.01%	707
2021 Q3	$6K	Hold	202	–	–	﹤0.01%	652
2021 Q2	$6K	Sell	202 -2	-1%	-$59	﹤0.01%	676
2021 Q1	$5K	Buy	+204	New	+$5.22K	﹤0.01%	714

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Carolinas Wealth Consulting's MD Position: Q2 2024 in Review

Carolinas Wealth Consulting sold out of Pediatrix Medical (MD) in Q2 2024, closing a stake of 167 shares — an estimated $1.68K sold.

Carolinas Wealth Consulting first reported a position in MD in Q1 2021 and held it in 13 quarters. The position peaked at $6K in Q3 2021. 227 funds tracked by Wall St. Rank hold MD as of Q2 2024.

Carolinas Wealth Consulting reported no remaining Pediatrix Medical position as of Q2 2024 after selling out during the quarter.
Carolinas Wealth Consulting sold 167 Pediatrix Medical shares in Q2 2024, an estimated $1.68K.
Carolinas Wealth Consulting first reported a position in Pediatrix Medical in Q1 2021 and held it in 13 quarters.
Carolinas Wealth Consulting's Pediatrix Medical position peaked at $6K in Q3 2021.
227 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2024.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2024, filed 12 Aug 2024.